Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-157 | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 66.7 | uM | 12594.167 | 1.0056 | 1.0079 | 1.4099 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10642.142 | 0.9840 | 0.9366 | 0.5006 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10642.142 | 0.9929 | 0.9716 | 0.5006 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10642.142 | 0.9758 | 0.9046 | 0.5006 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 10642.142 | 1.0012 | 1.0046 | 0.5006 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 10642.142 | 0.9895 | 0.9584 | 0.5006 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 10642.142 | 0.9953 | 0.9814 | 0.5006 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 10642.142 | 0.9923 | 0.9693 | 0.5006 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 10642.142 | 1.0284 | 1.1152 | 0.5006 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 10642.142 | 1.0194 | 1.0785 | 0.5006 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10818.154 | 0.9649 | 0.8637 | 0.5056 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10818.154 | 0.9620 | 0.8524 | 0.5056 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10818.154 | 0.9933 | 0.9734 | 0.5056 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 10818.154 | 1.0102 | 1.0407 | 0.5056 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 10818.154 | 1.0128 | 1.0508 | 0.5056 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 10818.154 | 0.9506 | 0.8092 | 0.5056 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 10818.154 | 1.0057 | 1.0228 | 0.5056 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 10818.154 | 0.9718 | 0.8900 | 0.5056 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 10818.154 | 0.9861 | 0.9452 | 0.5056 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 12126.154 | 0.9397 | 0.8034 | 0.6012 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 12126.154 | 0.8597 | 0.5554 | 0.6012 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 12126.154 | 0.9292 | 0.7699 | 0.6012 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 12126.154 | 0.8952 | 0.6635 | 0.6012 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 12126.154 | 0.9051 | 0.6945 | 0.6012 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 12126.154 | 0.9125 | 0.7174 | 0.6012 |